Genmab
Angela Liu serves as Vice President and Global Head of Operational Excellence at Genmab since October 2020, where notable contributions include leadership of over 75 associates and implementation of change management strategies across various global functions. Prior to Genmab, Angela held multiple vice president roles at Novartis Oncology from April 2003 to September 2020, culminating in the position of Executive Director for Strategic Development within the Oncology Global Development Unit. Angela's extensive experience includes shaping strategic direction for oncology clinical development and leading global clinical trial teams throughout various phases of research. With a strong academic background from Rutgers University in Clinical Research Oncology and Pharmaceutical Sciences, Angela brings a wealth of expertise to the pharmaceutical and biotechnology sectors.
This person is not in any teams
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.